Issued Patents All Time
Showing 51–75 of 99 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10858451 | Bispecific antibodies that bind to CD38 and CD3 | Seung Chu, Gregory Moore, John Desjarlais | 2020-12-08 |
| 10851178 | Heterodimeric human IgG1 polypeptides with isoelectric point modifications | Gregory Moore, John Desjarlais, Rumana Rashid | 2020-12-01 |
| 10793632 | Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors | Gregory Moore, John Desjarlais, Michael Hedvat, Christine Bonzon | 2020-10-06 |
| 10787518 | Bispecific checkpoint inhibitor antibodies | Gregory Moore, John Desjarlais, Michael Hedvat, Christine Bonzon, Alex Nisthal | 2020-09-29 |
| 10752678 | Complement component C5 antibodies | Peter C. Baciu, Yanbin Liang, Jason Guu, Umesh Muchhal, John Desjarlais | 2020-08-25 |
| 10738132 | Heterodimeric proteins | John Desjarlais, Gregory Moore, Rumana Rashid | 2020-08-11 |
| 10738133 | Heterodimeric proteins | Gregory Moore, Rumana Rashid, John Desjarlais | 2020-08-11 |
| 10626182 | Optimized antibodies that target CD19 | Seung Chu, John Desjarlais, Sher Bahadur Karki, Gregory Alan Lazar, Erik Weiking Pong +2 more | 2020-04-21 |
| 10550185 | Bispecific heterodimeric fusion proteins containing IL-15-IL-15Rα Fc-fusion proteins and PD-1 antibody fragments | Rumana Rashid, John Desjarlais, Rajat Varma, Christine Bonzon | 2020-02-04 |
| 10544187 | Targeting regulatory T cells with heterodimeric proteins | Seung Chu, Dilki Wickramarachchi, John Desjarlais | 2020-01-28 |
| 10526417 | Heterodimeric antibodies that bind CD3 and CD38 | Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal | 2020-01-07 |
| 10519242 | Targeting regulatory T cells with heterodimeric proteins | Seung Chu, Dilki Wickramarachchi, John Desjarlais | 2019-12-31 |
| 10501543 | IL15/IL15Rα heterodimeric Fc-fusion proteins | Rumana Rashid, John Desjarlais, Rajat Varma, Christine Bonzon | 2019-12-10 |
| 10487155 | Heterodimeric proteins | Gregory Moore, Rumana Rashid, John Desjarlais | 2019-11-26 |
| 10472427 | Heterodimeric proteins | John Desjarlais, Gregory Moore, Rumana Rashid | 2019-11-12 |
| 10259887 | Heterodimeric antibodies that bind CD3 and tumor antigens | Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal +1 more | 2019-04-16 |
| 10227411 | Modulation of T cells with bispecific antibodies and FC fusions | Seung Chu, Dilki Wickramarachichi, John Desjarlais | 2019-03-12 |
| 10155800 | CTLA4-Ig immunoadhesins | Gregory Alan Lazar | 2018-12-18 |
| 10131710 | Optimized antibody variable regions | Gregory Moore, Rumana Rashid, John Desjarlais | 2018-11-20 |
| 10106624 | Heterodimeric proteins | Gregory Moore, John Desjarlais, Rumana Rashid | 2018-10-23 |
| 9932395 | Nucleic acids encoding complement component C5 antibodies | Peter C. Baciu, Yanbin Liang, Jason Guu, Umesh Muchhal, John Desjarlais | 2018-04-03 |
| 9856327 | Heterodimeric antibodies to CD3 X CD123 | Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal +1 more | 2018-01-02 |
| 9850320 | Heterodimeric antibodies to CD3 X CD20 | Gregory Moore, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal +1 more | 2017-12-26 |
| 9822186 | Bispecific antibodies that bind to CD38 and CD3 | Seung Chu, Gregory Moore, John Desjarlais | 2017-11-21 |
| 9803020 | Optimized antibodies that target CD19 | Seung Chu, John Desjarlais, Sher Bahadur Karki, Gregory Alan Lazar, Erik Weiking Pong +2 more | 2017-10-31 |